首页> 外文期刊>The American Journal of the Medical Sciences >Intractable ascites, changes in serum vascular endothelial growth factor levels and thalidomide treatment in POEMS syndrome
【24h】

Intractable ascites, changes in serum vascular endothelial growth factor levels and thalidomide treatment in POEMS syndrome

机译:POEMS综合征的顽固性腹水,血清血管内皮生长因子水平变化和沙利度胺治疗

获取原文
获取原文并翻译 | 示例
           

摘要

POEMS, which stands for polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes, is a rare multisystem disorder without definite etiology that presents a diagnostic dilemma for the physician. According to the criteria for POEMS syndrome, the diagnosis requires 2 mandatory criteria (polyneuropathy and monoclonal plasma cell proliferative disorder), 1 of the 3 other major criteria (sclerotic bone lesions, Castleman's disease, elevated level of serum or plasma vascular endothelial growth factor [VEGF]) and 1 of the 6 minor criteria (organomegaly, extra-vascular volume overload, endocriiiopathy, skin changes, pap-illedema, thrombocytosis and/or polycythemia).
机译:POEMS代表多发性神经病,器质性肿大,内分泌病,单克隆丙种球蛋白病和皮肤变化,是一种罕见的多系统疾病,没有明确的病因,给医生带来了诊断上的两难选择。根据POEMS综合征的标准,诊断需要2项强制性标准(多发性神经病和单克隆浆细胞增殖性疾病),其他3项主要标准(硬化性骨病变,Castleman病,血清或血浆血管内皮生长因子水平升高)[ VEGF])和6个次要标准中的1个(器官肿大,血管外容量超负荷,内分泌病,皮肤变化,巴氏水肿,血小板增多和/或红细胞增多症)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号